Bioptik Technology (4161) — Cash Flow Quality Index
Bioptik Technology (4161) has a Cash Flow Quality Index of 2.03x as of December 2025. Operating cash flow of NT$53.21 Million exceeds net income of NT$26.24 Million, indicating high earnings quality where cash backs reported profits. Explore Bioptik Technology (4161) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bioptik Technology Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Bioptik Technology across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Bioptik Technology cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Bioptik Technology (2018–2025)
Year-by-year earnings quality comparison for Bioptik Technology. For live market cap and the full company financial profile, see Bioptik Technology market capitalisation.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.84x | NT$59.99 Million | NT$71.19 Million | ▼ -50.4% |
| 2024 | 1.70x | NT$158.82 Million | NT$93.57 Million | ▼ -12.3% |
| 2023 | 1.93x | NT$205.95 Million | NT$106.47 Million | ▲ +120.7% |
| 2022 | 0.88x | NT$55.06 Million | NT$62.81 Million | ▲ +141.8% |
| 2021 | -2.10x | NT$-41.15 Million | NT$19.62 Million | ▼ -126.8% |
| 2019 | 7.81x | NT$41.03 Million | NT$5.25 Million | ▲ +393.0% |
| 2018 | 1.59x | NT$41.83 Million | NT$26.39 Million | — |